Your browser doesn't support javascript.
loading
Pressure alopecias: A review.
Corona-Rodarte, Eduardo; Cano-Aguilar, Luis Enrique; Baldassarri-Ortego, Luisa Fernanda; Tosti, Antonella; Asz-Sigall, Daniel.
Affiliation
  • Corona-Rodarte E; Department of Dermatology, Instituto Dermatológico de Jalisco José Barba Rubio, Zapopan, Mexico. Electronic address: eduardo.coronar@incmnsz.mx.
  • Cano-Aguilar LE; Department of Dermatology, Hospital General "Dr. Manuel Gea González," Mexico City, Mexico.
  • Baldassarri-Ortego LF; Private Practitioner, Mexico City, Mexico.
  • Tosti A; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.
  • Asz-Sigall D; Trichology Clinic, Department of Dermatology, Hospital General "Dr. Manuel Gea González," Mexico City, Mexico. Electronic address: dasck@hotmail.com.
J Am Acad Dermatol ; 90(1): 125-132, 2024 01.
Article in En | MEDLINE | ID: mdl-37454698
ABSTRACT
Pressure-induced alopecias (PAs) are an infrequent group of scarring and nonscarring alopecias that occur after ischemic obstruction of capillaries that leads to circumscribed areas of hair loss. Initially described after prolonged surgeries or immobilization, type 1 PA occurs after sustained external pressure to the skin, mainly the scalp prominences. Alopecia induced by cosmetic procedures, referred in this review as type 2 PA, is reported with increased frequency in literature and predominantly emerges from pressure exerted by the volume of injectables. It is important to differentiate type 2 PA from vascular occlusion-induced alopecia because they represent distinct entities. Clinically, PA may present with erythema, swelling, and tenderness; however, alopecia might be the sole manifestation. Crusts and ulceration are associated with a worse outcome and a higher risk of scarring alopecia. Prompt diagnosis is paramount to prevent complications. Trichoscopy, although considered nonspecific, may provide relevant clues for an accurate diagnosis. Hair regrows in most cases, but prognosis depends on ischemia severity and timely treatment with reperfusion therapies or mobilization. Treatment of hair loss is usually not necessary because the disease in most cases is self-limited and reversible. The role of topical minoxidil and corticosteroids remains unknown.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cicatrix / Alopecia Limits: Humans Language: En Journal: J Am Acad Dermatol Year: 2024 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cicatrix / Alopecia Limits: Humans Language: En Journal: J Am Acad Dermatol Year: 2024 Type: Article